Equillium (EQ) Receivables - Other (2022 - 2025)

Equillium's (EQ) quarterly Receivables - Other came in at $108000.0 in Q4 2025, down 39.33% year-on-year from $178000.0 in Q4 2024, and down 12.2% on a QoQ basis from $123000.0 in Q3 2025.

Equillium (EQ) Receivables - Other (2022 - 2025) Analysis & Trends

Equillium (EQ) has 4 years of Receivables - Other data on file, last reported at $108000.0 in Q4 2025.

  • On a quarterly basis, Receivables - Other fell 39.33% year-over-year to $108000.0 in Q4 2025; TTM through Dec 2025 was $108000.0, a 39.33% decrease from a year earlier, with the FY2025 full-year figure at $108000.0, down 39.33% from the prior year.
  • Receivables - Other for Q4 2025 stood at $108000.0, down from $123000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for EQ reached as high as $497000.0 in Q4 2023 and fell as low as $35000.0 in Q2 2025.
  • Historically, Receivables - Other has averaged $245200.0 across 4 years, with a median of $223500.0 in 2022.
  • Across the five-year window, Receivables - Other jumped 84.76% in 2023 and tumbled 91.4% in 2025, its largest moves.
  • Year by year, Receivables - Other stood at $269000.0 in 2022, then soared by 84.76% to $497000.0 in 2023, then slumped by 64.19% to $178000.0 in 2024, then plunged by 39.33% to $108000.0 in 2025.
  • Per Business Quant data, the three most recent Receivables - Other figures were $108000.0 in Q4 2025, $123000.0 in Q3 2025, and $35000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Equillium 258.99 Mn 258.99 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 108,000.00
Dec 31, 2025 108,000.00
Sep 30, 2025 123,000.00
Sep 30, 2025 123,000.00
Jun 30, 2025 35,000.00
Jun 30, 2025 35,000.00
Mar 31, 2025 73,000.00
Mar 31, 2025 73,000.00
Dec 31, 2024 178,000.00
Dec 31, 2024 178,000.00
Sep 30, 2024 275,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 407,000.00
Jun 30, 2024 407,000.00
Mar 31, 2024 487,000.00
Mar 31, 2024 487,000.00
Dec 31, 2023 497,000.00
Dec 31, 2023 497,000.00
Dec 31, 2022 269,000.00
Dec 31, 2022 269,000.00